Back
Chemomab Therapeutics Stock Predictions
10 Best Stocks to Own in 2025
Get your copy now FREE!
Buy
59
CMMB
Chemomab Therapeutics
Last Price:
$1.31
Seasonality Move:
-10.03%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREEChemomab Therapeutics Stock Forecast
-
Is Chemomab Therapeutics Stock Undervalued?The current Chemomab Therapeutics [CMMB] share price is $1.36. The Score for CMMB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CMMB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Chemomab Therapeutics Stock Go Up Next Year?
Data Unavailable
Chemomab Therapeutics Stock Rating
Data Unavailable
Chemomab Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
chemomab.com
52-Week Data
52-Week High:
2.55
52-Week Low:
0.78
Prediction Charts
Market Cap:
25.7M
Price in USD:
1.36
Volume:
40.3K
Beta:
0.70
Technical Analysis
SMA50:
1.23
SMA100:
1.55
SMA200:
1.57
52-Wk Change:
43.42%
Stock Predictions
-
Is Chemomab Therapeutics stock public?Yes, Chemomab Therapeutics is a publicly traded company.
-
What is the Chemomab Therapeutics stock quote today?The Chemomab Therapeutics stock price is 1.36 USD today.
-
How to buy Chemomab Therapeutics stock online?You can buy Chemomab Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-9 | 1.21 | 1.26 | 1.31 | 1.21 |
| May-12 | 1.28 | 1.24 | 1.30 | 1.23 |
| May-13 | 1.23 | 1.26 | 1.29 | 1.23 |
| May-14 | 1.27 | 1.21 | 1.28 | 1.14 |
| May-15 | 1.19 | 1.29 | 1.30 | 1.17 |
| May-16 | 1.29 | 1.37 | 1.41 | 1.29 |
| May-19 | 1.38 | 1.39 | 1.46 | 1.36 |
| May-20 | 1.39 | 1.39 | 1.47 | 1.37 |
| May-21 | 1.39 | 1.38 | 1.43 | 1.33 |
| May-22 | 1.36 | 1.36 | 1.39 | 1.31 |
| May-23 | 1.35 | 1.37 | 1.39 | 1.34 |
| May-27 | 1.38 | 1.40 | 1.44 | 1.37 |
| May-28 | 1.43 | 1.37 | 1.43 | 1.36 |
| May-29 | 1.37 | 1.36 | 1.39 | 1.36 |
Chemomab Therapeutics Earnings
Data Unavailable
Chemomab Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.01 per share.
* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.